Prediction: New Reason Lilly Stock Could Still Rise
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
Personal financial planning is vital for achieving long-term financial goals. Learn why it matters and how to get started effectively.
24,445 articlesEli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
Meta Platforms expands its lead in scalable ads and AI infrastructure, widening the gap to Palantir, whose high multi...
IBM issued a profit warning, signaling a hardware-led pullback that could temper its software-led growth. Investors a...
The July Fourth week masked the broader strength in local housing markets. National data showed seasonal lull, but th...
Investors are weighing two AI powerhouses: Amazon and Alphabet. This guide breaks down which may offer the stronger p...
JPMorgan CEO Jamie Dimon outlined a plan to fix a looming shipbuilding labor gap, arguing 300,000 skilled trades work...
Rocket Lab shares hover near $67 as July odds tilt toward downside. This story breaks down what prediction markets be...
Memory chips power today’s data centers, AI accelerators, and personal devices. This guide breaks down the case for S...
Korea’s rapid AI-driven swings in key chip names are starting the day for traders around the world. The Kospi’s volat...
Gold ETFs still track spot prices, but GLD's 0.40% expense ratio is quietly eroding long-term gains. Through mid-2026...
Vanguard's Dividend Appreciation ETF (VIG) yields about 1.5% today, but behind that modest payout lies a 20-year stre...
Small-cap artificial intelligence stocks under $10 are rallying as enterprise AI demand grows, but investors face vol...